Growth Capitalist (https://growthcapitalist.com/author/moriarty/page/184/)
Progenics Pharmaceuticals, Inc. (PGNX) announced that it has secured up to $50,000,000 in an ATM (At the Market) transaction with Cantor Fitzgerald & Company. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was Latham & Watkins and issuer counsel was O'Melveny & Myers. An agreement was reached on January 23, 2014. via PlacementTracker.
ThermoGenesis Corporation (KOOL) announced that it has raised $6,670,000 in a Common Stock transaction. The common stock was sold at $2.00 per share, an approximate 29% discount to the market price ($2.82) of KOOL at deal announcement. A series of 1,667,500 60-Month Warrants with an exercise price of $2.81 per share (0.35% discount) was issued to the investors in this transaction. Maxim Group LLC acted as the exclusive agent on the transaction. The transaction is expected to close by 01/30/2014.
Kips Bay Medical, Inc. (KIPS) announced that it has raised $3,675,000 in a CMPO/Overnight transaction. The common stock was sold at $0.70 per share, an approximate 17% discount to the market price ($0.84) of KIPS at deal announcement. Aegis Capital Corporation acted as Sole Book-Runner on the transaction. Underwriter counsel was Reed Smith, LLP and issuer counsel was Oppenheimer Wolff & Donnelly, LLP. The transaction is expected to close by 01/29/2014.
Santa Fe Gold Corporation (SFEG) announced that it has raised $3,000,000 in a Non-Convertible Debentures transaction. The securities accrue interest at a rate of 18%. The investor was Tyhee Gold Corporation. Concurrently with this Placement, Tyhee Gold Corporation completed a reverse merger with the Company. The principal amount of the Debentures becomes due and payable upon termination of the merger agreement with the Investor or, following completion of the merger, will be converted to an intercompany loan.
